Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W J Strachan

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Diabetes Care|January 26, 2010
Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes studyRebecca M Reynolds, Mark W J Strachan, Javier Labad, et al.
BMC Endocrine Disorders|December 17, 2008
The Edinburgh Type 2 Diabetes Study: study protocolJackie F Price, Rebecca M Reynolds, Rory J Mitchell, et al.
Human Molecular Genetics|March 4, 2010
Variation in the uric acid transporter gene (SLC2A9) and memory performanceLorna M Houlihan, Niki D Wyatt, Sarah E Harris, et al.
Journal of Hypertension|March 16, 2013
Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes studyWei Leng Teoh, Jackie F Price, Rachel M Williamson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Diabetes Care|April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRachel M Williamson, Jackie F Price, Stephen Glancy, et al.
BMC Pregnancy and Childbirth|September 24, 2017
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trialRebecca M Reynolds, Fiona C Denison, Ed Juszczak, et al.
Obesity Science & Practice|October 11, 2021
Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes StudySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
Diabetes Care|April 13, 2013
Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyInsa Feinkohl, Marketa Keller, Christine M Robertson, et al.
Kidney International|April 17, 2016
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetesBoris B Betz, Sara J Jenks, Andrew D Cronshaw, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Diabetes Care|January 26, 2010
Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes studyRebecca M Reynolds, Mark W J Strachan, Javier Labad, et al.
BMC Endocrine Disorders|December 17, 2008
The Edinburgh Type 2 Diabetes Study: study protocolJackie F Price, Rebecca M Reynolds, Rory J Mitchell, et al.
Human Molecular Genetics|March 4, 2010
Variation in the uric acid transporter gene (SLC2A9) and memory performanceLorna M Houlihan, Niki D Wyatt, Sarah E Harris, et al.
Journal of Hypertension|March 16, 2013
Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes studyWei Leng Teoh, Jackie F Price, Rachel M Williamson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Diabetes Care|April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRachel M Williamson, Jackie F Price, Stephen Glancy, et al.
BMC Pregnancy and Childbirth|September 24, 2017
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trialRebecca M Reynolds, Fiona C Denison, Ed Juszczak, et al.
Obesity Science & Practice|October 11, 2021
Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes StudySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
Diabetes Care|April 13, 2013
Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyInsa Feinkohl, Marketa Keller, Christine M Robertson, et al.
Kidney International|April 17, 2016
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetesBoris B Betz, Sara J Jenks, Andrew D Cronshaw, et al.
Pageof 11